GPR34: A GPCR Gene Regulating Cell Signaling (G2857)

Target Name: GPR34

NCBI ID: G2857

GPR34

GPR34: A GPCR Gene Regulating Cell Signaling

GPR34, also known as G protein-coupled receptor 34, is a protein that is expressed in many different tissues throughout the body. It is a member of the G protein-coupled receptor (GPCR) family, which is a large superfamily of transmembrane proteins that play a critical role in cellular signaling. GPR34 is a transcript variant of GPCR34, and it is one of the most well-studied GPCR genes.

GPR34 is a key regulator of cell signaling pathways that are involved in a wide range of physiological processes, including sensory perception, neurotransmission, and hormone signaling. It is involved in the transduction of signals from the cell surface to the inside of the cell, and it is involved in the regulation of a wide range of cellular processes, including cell growth, differentiation, and apoptosis.

GPR34 is a potential drug target because of its involvement in cellular signaling pathways. Many diseases are caused by the disruption of normal cellular signaling pathways, and GPR34 may be a useful target for the development of new treatments. For example, GPR34 has been shown to be involved in the regulation of pain perception, and it may be a useful target for the development of pain medications. Additionally, GPR34 is involved in the regulation of neurotransmission, and it may be a useful target for the development of neurotransmitter antagonists.

In addition to its potential as a drug target, GPR34 is also a potential biomarker for the diagnosis and monitoring of certain diseases. For example, GPR34 has been shown to be involved in the regulation of anxiety and depression, and it may be a useful biomarker for the diagnosis and treatment of these conditions. Additionally, GPR34 may be involved in the regulation of inflammation, and it may be a useful biomarker for the diagnosis and treatment of inflammatory diseases.

GPR34 is also a potential target for small molecule inhibitors, which may be used to modulate the activity of GPR34. Many small molecules have been shown to interact with GPR34, and the identification of these molecules may provide new insights into the regulation of GPCR signaling pathways.

In conclusion, GPR34 is a well-studied GPCR gene that is involved in the regulation of cell signaling pathways. Its potential as a drug target and biomarker make it an attractive target for the development of new treatments for a wide range of diseases. Further research is needed to fully understand the regulation of GPR34 and its potential as a drug and biomarker.

Protein Name: G Protein-coupled Receptor 34

Functions: Orphan receptor

The "GPR34 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPR34 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets